Gene · 51094
Papers2,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Linking HLA class II susceptibility to HSPC transcriptomics and antigen presentation in aplastic anemia. | Front Immunol | 2026 | 42774213 | PubTator, text mining | PubMed |
| AdipoRon, an Adiponectin Receptor Agonist, Promotes Intestinal Epithelial Differentiation in Caco-2 Colorectal Adenocarcinoma Cells. | Biomedicines | 2026 | 42652081 | PubTator, text mining | PubMed |
| Circulating Adipokines, Tissue Receptor Expression, and Body Composition: Clinical Relevance and Disease Stage in Epithelial Ovarian Carcinoma. | Cancers (Basel) | 2026 | 42650023 | PubTator, text mining | PubMed |
| Adiponectin improves clozapine-induced lipid accumulation and inflammation without affecting insulin resistance. | Open Life Sci | 2026 | 42491597 | PubTator, text mining | PubMed |
| Selective Small-Molecule AdipoR1 Agonist 3-Hydroxy Pterocarpan Salt (CDRI-1709S) Ameliorates Skeletal Muscle Atrophy. | J Cachexia Sarcopenia Muscle | 2026 | 42480512 | PubTator, text mining | PubMed |
| Distinct roles of AdipoR1 and AdipoR2 in modulating neuronal firing homeostasis in response to adiponectin and AdipoRon. | Cell Commun Signal | 2026 | 42402576 | PubTator, text mining | PubMed |
| Searching for New Genes That Cause Usher Syndrome. | Am J Ophthalmol | 2026 | 42309414 | PubTator, text mining | PubMed |
| NgBR controls hepatic adiponectin signaling competence through KAT7-dependent chromatin regulation. | bioRxiv | 2026 | 42239413 | PubTator, text mining | PubMed |
| Adiponectin and central nervous system disorders: Regulatory mechanisms and therapeutic potential. | Pharmacol Res | 2026 | 42173267 | PubTator, text mining | PubMed |
| Maternal opioids downregulate adiponectin receptor signaling and alter growth in offspring: pilot study. | Front Pediatr | 2026 | 41993904 | PubTator, text mining | PubMed |
| Circulating MicroRNA Profiling for Phenotypic Stratification in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease: A Candidate-Based Study. | Curr Issues Mol Biol | 2026 | 41899424 | PubTator, text mining | PubMed |
| AdipoR1-AMPK axis suppresses breast cancer across molecular subtypes via multimodal cell death pathways, including ferroptosis and apoptosis. | Cell Death Dis | 2026 | 41888104 | PubTator, text mining | PubMed |
| The promise of pectic oligosaccharides as a novel sustainable additive in poultry production: A systematic review. | Poult Sci | 2026 | 41850059 | PubTator, text mining | PubMed |
| Organophosphate pesticide DEDT promotes diabetic retinopathy progression via AMPK/Nrf2/HO-1 pathway. | Sci Rep | 2026 | 41839915 | PubTator, text mining | PubMed |
| AdipoRon alleviates cerebral ischemic injury through AMPK-dependent microglial autophagy and phenotypic modulation. | Mol Cell Neurosci | 2026 | 41833595 | PubTator, text mining | PubMed |
| Glucagon-Like Peptide-2 Ameliorates Lipid Metabolism in Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Adiponectin-Adiponectin Receptor-Mediated AMPK/PPARalpha Pathway. | Physiol Res | 2026 | 41811706 | PubTator, text mining | PubMed |
| The ethnicity and gut microbiota hypothesis: analyzing multifactorial interactions and their health implications. | Front Microbiol | 2026 | 41800419 | PubTator, text mining | PubMed |
| Navigating the potential of algal peptides: health effects, market applications, and scientific challenges. | Ann Med | 2026 | 41793777 | PubTator, text mining | PubMed |
| Age-related adiponectin resistance in human skeletal muscle dysfunction: in vivo and in vitro evidence. | J Transl Med | 2026 | 41787384 | PubTator, text mining | PubMed |
| Enzyme-Activated Self-Assembling Peptides Mimicking Adiponectin Multimers for Nonalcoholic Fatty Liver Disease Therapy. | ACS Cent Sci | 2026 | 41768763 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51094/papers